237TiP GUIDE.MRD: A Consortium guiding multi-modal therapies against minimal residual disease (MRD) by liquid biopsy to assess implementation of circulating tumor DNA (ctDNA) in clinical practice to improve patient outcomes
Pantel, K., Lindbjerg Andersen, C., Schuuring, E., Malats, N., Heitzer, E., Vat, L., Kiernan, E., Chin, E., Barrett, J.C., Kapp, J.R., Thomas, M., Gerling, M., Reck, M., Löhr, M., Hofman, P., Hiltermann, J.T.J.N., Alix-Panabières, C., Smit, D.J., Bolisetty, M., Karasarides, M.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article